As Cédric Moro explains to us, this drug is an analogue of GLP-1. This convoluted acronym stands for Glucagon Like Peptide-1, a small molecule that plays an essential role in maintaining blood sugar balance. This is why Ozempic, which acts in a similar way to this peptide, is indicated in France for the treatment of type 2 diabetes. Except that, through its action, this molecule will also increase the feeling of satiety in the patient. Since then, “we cannot refute the effectiveness of this family of molecules on weight loss”, as recognized by the specialist in diabetes research.
A study published on June 4 on the use of Tirzepatide, another antidiabetic, has indeed shown a 15% reduction in the starting weight of a group of diabetic patients whose average weight was 105 kg. This does not mean that these drugs can be administered to a healthy person. Quite the contrary.
